XOMA Royalty (XOMA) Operating Margin (2011 - 2026)
XOMA Royalty (XOMA) reported Operating Margin of 3.9% for Q1 2026, down 15212.0% on a YoY basis from N/an in Q1 2025, and down 124.57% sequentially from 15.86% in Q4 2025.
XOMA Royalty (XOMA) Operating Margin (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 16 years of Operating Margin data on file, last reported at 3.9% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 15212.0% year-over-year to 3.9%; the trailing twelve-month figure through Mar 2026 stood at 34.85% (up 19658.0% YoY), and the FY2025 full-year result was 21.83%, up 62297.0% from the prior year.
- Operating Margin retreated to 3.9% in Q1 2026, from 15.86% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 148.22% in Q1 2025 to a low of 2572.0% in Q3 2023.
- A 5-year average of 722.61% and a median of 414.68% in 2024 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin sank 1591309 bps in 2022 and surged 235469 bps in 2024, its largest moves.
- Tracing XOMA's Operating Margin over 5 years: stood at 730.59% in 2022, then tumbled by 110 bps to 1533.38% in 2023, then gained by 5 bps to 1450.6% in 2024, then jumped by 101 bps to 15.86% in 2025, then slumped by 125 bps to 3.9% in 2026.
- Business Quant data shows XOMA's Operating Margin at 3.9% in Q1 2026, 15.86% in Q4 2025, and 91.6% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | -3.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.90% |
| Dec 31, 2025 | 15.86% |
| Jun 30, 2025 | 91.60% |
| Mar 31, 2025 | 148.23% |
| Dec 31, 2024 | -1,450.60% |
| Sep 30, 2024 | -217.31% |
| Jun 30, 2024 | -200.58% |
| Mar 31, 2024 | -470.07% |
| Dec 31, 2023 | -1,533.38% |
| Sep 30, 2023 | -2,572.00% |
| Jun 30, 2023 | -359.29% |
| Mar 31, 2023 | -2,327.23% |
| Dec 31, 2022 | -730.59% |
| Sep 30, 2022 | -969.40% |
| Jun 30, 2022 | -908.00% |
| Mar 31, 2022 | -75.09% |
| Dec 31, 2021 | 15,182.50% |
| Sep 30, 2021 | -608.18% |
| Jun 30, 2021 | -340.07% |
| Mar 31, 2021 | -1,713.87% |